Small Molecules in Oncology

Editors:

ISBN: 978-3-642-54489-7 (Print) 978-3-642-54490-3 (Online)

Table of contents (25 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xvi

  2. No Access

    Book Chapter

    Pages 1-25

    Imatinib Mesylate

  3. No Access

    Book Chapter

    Pages 27-65

    Dasatinib

  4. No Access

    Book Chapter

    Pages 67-80

    Nilotinib

  5. No Access

    Book Chapter

    Pages 81-97

    Bosutinib: A Novel Second-Generation Tyrosine Kinase Inhibitor

  6. No Access

    Book Chapter

    Pages 99-107

    Ponatinib: A Third-Generation Inhibitor for the Treatment of CML

  7. No Access

    Book Chapter

    Pages 109-123

    Erlotinib

  8. No Access

    Book Chapter

    Pages 125-143

    Lapatinib

  9. No Access

    Book Chapter

    Pages 145-164

    Sorafenib: Targeting Multiple Tyrosine Kinases in Cancer

  10. No Access

    Book Chapter

    Pages 165-184

    Sunitinib in the Treatment of Advanced Solid Tumors

  11. No Access

    Book Chapter

    Pages 185-196

    Regorafenib

  12. No Access

    Book Chapter

    Pages 197-205

    Crizotinib

  13. No Access

    Book Chapter

    Pages 207-214

    Cabozantinib: A MET, RET, and VEGFR2 Tyrosine Kinase Inhibitor

  14. No Access

    Book Chapter

    Pages 215-225

    Vemurafenib

  15. No Access

    Book Chapter

    Pages 227-240

    Dabrafenib

  16. No Access

    Book Chapter

    Pages 241-248

    Trametinib

  17. No Access

    Book Chapter

    Pages 249-257

    Ruxolitinib

  18. No Access

    Book Chapter

    Pages 259-267

    Ibrutinib

  19. No Access

    Book Chapter

    Pages 269-297

    Decitabine

  20. No Access

    Book Chapter

    Pages 299-324

    5-Azacytidine/5-Azacitidine

  21. No Access

    Book Chapter

    Pages 325-345

    Bortezomib

previous Page of 2